ALX ONCOLOGY HOLDINGS INC (ALXO) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 259 transactions totaling $128.5M, demonstrating a bullish sentiment with $45.0M in net insider flow. The most recent transaction on Feb 17, 2026 involved a transaction of 2,201 shares valued at $5.0K.
No significant insider buying has been recorded for ALXO in the recent period.
No significant insider selling has been recorded for ALXO in the recent period.
Based on recent SEC filings, insider sentiment for ALXO is bullish with an Insider Alignment Score of 67/100 and a net flow of $45.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at ALX ONCOLOGY HOLDINGS INC (ALXO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading ALXO stock, having executed 259 transactions in the past 90 days. The most active insider is G. Walmsley Graham (Executive), who has made 3 transactions totaling $20.0M.
Get notified when executives and directors at ALXO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Lettmann Jason | Executive | Payment | 2,201 | $2.27 | $5.0K | |
| Jan 6, 2026 | Pinto Shelly | SVP, FINANCE AND CAO | Sale | 3,925 | $1.11 | $4.4K | |
| Sep 17, 2025 | Lettmann Jason | Executive | Purchase | 71,163 | $1.08 | $76.9K | |
| Sep 16, 2025 | Lettmann Jason | Executive | Purchase | 21,070 | $1.07 | $22.5K | |
| Aug 18, 2025 | Shantharam Harish | Executive | Purchase | 75,000 | $0.78 | $58.5K | |
| Aug 15, 2025 | Lettmann Jason | Executive | Sale | 2,382 | $0.64 | $1.5K | |
| Aug 15, 2025 | Pinto Shelly | Executive | Sale | 611 | $0.64 | $391 | |
| Jul 7, 2025 | Pinto Shelly | Executive | Sale | 2,011 | $0.45 | $905 | |
| Jun 30, 2025 | Pinto Shelly | Executive | Sale | 1,532 | $0.43 | $659 | |
| Aug 14, 2024 | Lettmann Jason | Executive | Payment | 2,191 | $2.58 | $5.7K | |
| Aug 14, 2024 | Pons Jaume | Executive | Sale | 1,937 | $2.58 | $5.0K | |
| Aug 14, 2024 | S. Garcia Peter | Executive | Payment | 761 | $2.58 | $2.0K | |
| Aug 14, 2024 | Randolph Sophia | Executive | Sale | 1,365 | $2.58 | $3.5K | |
| Aug 14, 2024 | Pinto Shelly | Executive | Sale | 564 | $2.58 | $1.5K | |
| Jul 11, 2024 | Pons Jaume | Executive | Option Exercise | 20,000 | $0.99 | $19.8K | 10b5-1 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 20 | $86.7M | 67.0% |
Sale(S) | 176 | $41.8M | 32.2% |
Exercise(M) | 26 | $1.0M | 0.8% |
Payment(F) | 3 | $12.6K | 0.0% |
Award(A) | 14 | $0 | 0.0% |
Conversion(C) | 20 | $0 | 0.0% |
Insiders at ALX ONCOLOGY HOLDINGS INC are accumulating shares at an accelerated pace. With 15 insiders making 259 transactions totaling $86.7M in purchases versus $41.8M in sales, the net buying activity of $45.0M signals strong executive confidence. G. Walmsley Graham (Executive) leads the buying activity with $20.0M in transactions across all time.